| |
| |
|
| Insider
Information: |
Vincent Aurentz |
| Relationship: |
Executive VP and CBO |
| City: |
Boston |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
2,200 |
|
|
Indirect Shares
|
2,800 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
5,000 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Epirus Biopharmaceuticals Inc |
EPRS |
Chief Business Officer |
2015-12-17 |
2,200 |
2015-12-17 |
2,800 |
Premium* |
|
|
Arena Pharmaceuticals Inc |
ARNA |
Executive VP and CBO |
2022-03-11 |
0 |
2019-09-09 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
15 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ARNA |
Arena Pharmaceuticals Inc |
Executive VP and CBO |
• – – |
2022-03-11 |
4 |
D |
$0.00 |
$0 |
D/D |
(55,964) |
0 |
0 |
- |
|
| ARNA |
Arena Pharmaceuticals Inc |
Executive VP and CBO |
• – – |
2022-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
21,462 |
55,122 |
0 |
- |
|
| ARNA |
Arena Pharmaceuticals Inc |
Executive VP and CBO |
• – – |
2021-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
6,660 |
33,660 |
0 |
- |
|
| ARNA |
Arena Pharmaceuticals Inc |
Executive VP and CBO |
• – – |
2021-02-16 |
4 |
AS |
$85.00 |
$214,540 |
D/D |
(2,524) |
27,000 |
0 |
% |
|
| ARNA |
Arena Pharmaceuticals Inc |
Executive VP and CBO |
• – – |
2021-02-16 |
4 |
OE |
$14.60 |
$37,354 |
D/D |
2,524 |
29,524 |
0 |
- |
|
| ARNA |
Arena Pharmaceuticals Inc |
Executive VP and CBO |
• – – |
2021-01-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,000 |
27,000 |
0 |
- |
|
| ARNA |
Arena Pharmaceuticals Inc |
Executive VP and CBO |
• – – |
2020-11-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,000 |
9,000 |
0 |
- |
|
| ARNA |
Arena Pharmaceuticals Inc |
Executive VP and CBO |
• – – |
2020-06-02 |
4 |
AS |
$65.00 |
$1,625,023 |
D/D |
(25,000) |
0 |
0 |
% |
|
| ARNA |
Arena Pharmaceuticals Inc |
Executive VP and CBO |
• – – |
2020-06-02 |
4 |
OE |
$14.60 |
$495,000 |
D/D |
25,000 |
25,000 |
0 |
- |
|
| ARNA |
Arena Pharmaceuticals Inc |
Executive VP and CBO |
• – – |
2020-02-05 |
4 |
AS |
$50.00 |
$450,000 |
D/D |
(9,000) |
0 |
0 |
% |
|
| ARNA |
Arena Pharmaceuticals Inc |
Executive VP and CBO |
• – – |
2019-10-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,000 |
9,000 |
0 |
- |
|
| ARNA |
Arena Pharmaceuticals Inc |
Executive VP and CBO |
• – – |
2019-09-09 |
4 |
AS |
$50.48 |
$3,296,700 |
D/D |
(65,000) |
0 |
0 |
- |
|
| ARNA |
Arena Pharmaceuticals Inc |
Executive VP and CBO |
• – – |
2019-09-09 |
4 |
OE |
$14.60 |
$1,641,500 |
D/D |
65,000 |
65,000 |
0 |
- |
|
| EPRS |
Epirus Biopharmaceuticals... |
Chief Business Officer |
• – – |
2015-12-17 |
4 |
B |
$3.43 |
$7,546 |
D/D |
2,200 |
2,200 |
2.74 |
- |
|
| EPRS |
Epirus Biopharmaceuticals... |
Chief Business Officer |
• – – |
2015-12-09 |
4 |
B |
$3.85 |
$10,780 |
I/I |
2,800 |
2,800 |
1.99 |
- |
|
15 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
